Catalyst Wire Dossier Catalyst Wire Dossier

4F-PCC (4-Factor Prothrombin Complex Concentrate)

four-factor prothrombin complex concentrate · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4F-PCC (4-Factor Prothrombin Complex Concentrate), covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB) [Phase 3]

See pricing